HB4099, titled the “Ensuring Women’s Right to Reproductive Freedom Act,” would bar state and local officials acting under color of state law from interfering with abortion services that are lawful in the state where they are provided, when the patient is from another state. The bill protects a broad set of activities, including a provider’s ability to perform or facilitate the abortion, third-party assistance to the provider, a person’s travel across state lines to obtain the service, assistance to that traveler, and the interstate movement of FDA-approved drugs used to terminate a pregnancy.
The bill also creates federal enforcement mechanisms. The U.S. Attorney General could seek declaratory and injunctive relief in federal court against violators, and private parties harmed by a violation could sue for injunctive relief, compensatory damages, emotional distress damages, and attorney’s fees. The bill defines “abortion service” broadly to include the abortion itself and related health care services, and it defines “health care provider” to include physicians, nurse-midwives, nurse practitioners, physician assistants, and pharmacists licensed or certified under applicable state law.
In terms of state law impact, the measure would limit the ability of states to enforce laws or take retaliatory action that burden interstate abortion access, especially in situations where a patient travels from a restrictive state to a permissive one. It would apply to states, the District of Columbia, U.S. territories, and Indian tribes, and it includes severability and a rule of construction preserving the fundamental right to travel. The practical effect would be to preempt or constrain state-level efforts aimed at deterring out-of-state abortion access or restricting the transport of abortion medication in interstate commerce.
The available context shows no committee hearing transcript and no recorded votes, so there is no documented floor or committee sentiment in the provided materials. Based on the bill’s sponsorship and text, the measure is clearly framed as a reproductive-rights protection bill, and its supporters appear to view it as safeguarding interstate travel and access to lawful medical care. Because there is no recorded opposition in the supplied context, the general sentiment is best characterized as supportive among sponsors, with controversy likely centered on federalism and state authority rather than on procedural history.
The main point of contention is the bill’s reach into state enforcement powers. Opponents would likely argue that it interferes with states’ ability to regulate abortion-related conduct and to police conduct by providers, helpers, or drug distribution connected to abortion services. Supporters would likely emphasize that it protects interstate travel, shields providers and helpers from retaliation, and preserves access to lawful care in states where abortion remains legal. The bill’s inclusion of abortion medication in interstate commerce and its private right of action make it especially significant for both reproductive health providers and state officials.
HB4099 would create a federal prohibition on state-law interference with interstate abortion services and would authorize both federal and private enforcement. It would affect state and territorial officials, health care providers, helpers, travelers, and the interstate movement of FDA-approved abortion drugs by limiting state actions that prevent, restrict, impede, or retaliate against those activities. In practice, it would constrain state abortion-enforcement efforts that reach beyond a state’s borders and would add new civil remedies in federal court.
No committee transcript or vote history was provided, so there is no recorded legislative debate or roll-call sentiment to summarize. From the bill text and sponsor list, the measure appears to have been introduced in a strongly supportive, pro-reproductive-freedom posture. The overall framing is protective of abortion access and interstate travel, suggesting support from sponsors and likely allied members, while opposition would be expected from lawmakers favoring state abortion restrictions and broader state regulatory authority.
The central controversy is federal preemption versus state authority. Supporters are likely to argue that states should not be allowed to punish or obstruct people traveling for lawful abortion care or providers assisting them, especially where the procedure is legal in the destination state. Opponents are likely to object that the bill would limit states’ ability to enforce their own abortion-related laws, including actions related to providers, assistants, and abortion medication. The private right of action, damages provision, and interstate-drug language are also likely to be contentious.